ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Insulin Aspart

Also written as “insulin aspart”, “biphasic insulin aspart” and “Faster-acting insulin aspart”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Diabetes, Gestational, led by 9 companies.

Drug pageInsulin Aspart: every studyMany companies study it; this page follows only the 139 they lead. All 207 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Nov 4, 2004139 company-led studies, 1 open or runningNext primary completion: Dec 2026

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Novo Nordisk1280 open or runningphase 4since Nov 4, 2004Jul 17, 2003none ahead
Amphastar Pharmaceuticalsits history only20 open or runningphase 3since Sep 12, 2022Sep 12, 2022none ahead
Geropharmits history only20 open or runningphase 3since Sep 3, 2019Sep 3, 2019none ahead
Profil Institut für Stoffwechselforschungits history only20 open or runningphase 1since Aug 8, 2007Aug 8, 2007none ahead
CeQurits history only10 open or runningno phasesince Mar 24, 2015Mar 24, 2015none ahead
Defymedits history only11 open or runningno phasesince Dec 3, 2021Dec 3, 2021Dec 2026NCT05221359
Sunshine Lake Pharmaits history only10 open or runningphase 3since Mar 6, 2023Mar 6, 2023none ahead
The United Laboratories Internationalits history only10 open or runningno phasesince May 6, 2026May 6, 2026none ahead
Tonghua Dongbao Pharmaceuticalits history only10 open or runningphase 3since Jun 5, 2015Jun 5, 2015none ahead

Also a collaborator on its studies: Mylan and Sanofi.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Novo Nordisk only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 42 studies since Nov 8, 2011.

  1. Jan 7, 2014Phase 3 study in Diabetes MellitusNCT02034513 · 501 enrolled · United States, Poland, Puerto Rico
  2. Jan 9, 20143 phase 1 studies in Diabetes MellitusNCT02033239, NCT02035371, NCT02089451
  3. May 2, 2014Phase 1 study in Diabetes MellitusNCT02131246 · 33 enrolled · Austria
  4. Jul 15, 2015Phase 3 study in Diabetes MellitusNCT02500706 · 1,108 enrolled · United States, Austria, Bulgaria and more
  5. Oct 2, 20152 phase 1 studies in Diabetes MellitusNCT02568280, NCT02594033
  6. Jan 5, 20162 phase 3 studies in Diabetes MellitusNCT02648217, NCT02670915
  7. May 3, 2016Phase 3 study in Diabetes MellitusNCT02762578 · 543 enrolled · China
  8. Jul 4, 2016Phase 3 study in Diabetes MellitusNCT02825251 · 472 enrolled · United States, Belgium, Canada and more
  9. Jul 22, 2016Phase 1 study in HealthyNCT02844790 · 24 enrolled · China
  10. Sep 15, 2016Phase 3 study in Diabetes MellitusNCT02906917 · 532 enrolled · United States, Algeria, Czechia and more
  11. Oct 13, 2016Phase 1 study in Diabetes MellitusNCT02933853 · 61 enrolled · Austria
  12. Jun 29, 2017Phase 1 study in Diabetes MellitusNCT03215498 · 58 enrolled · Germany
  13. Jan 5, 2018Phase 1 study in Diabetes MellitusNCT03407599 · 46 enrolled · Germany
  14. Jan 23, 2019Phase 2 study in Diabetes Mellitus, Type 1NCT03816761 · 24 enrolled · United States

TargetBeta

INSR →read by rule
“Insulin receptor agonist”ChEMBL 37, by rule

Other programs on INSR

ProgramCompanyFurthest phaseStudies
Insulin GlargineruleSanofiphase 4190
insulin degludecruleNovo Nordiskphase 4108
InsulinrulePfizerphase 450
insulin glulisineruleSanofiphase 443
insulin icodecruleNovo Nordiskphase 430
linsitinibruleAstellas Pharmaphase 313
LY3938577Eli Lillyphase 23

Studies

The newest 60 of 128 Novo Nordisk leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT03816761Diabetes Mellitus, Type 1 · United States2CompletedMay 31, 201924
NCT03407599Diabetes Mellitus · Germany1CompletedJul 5, 201846
NCT03215498Diabetes Mellitus · Germany1CompletedNov 20, 201758
NCT02933853Diabetes Mellitus · Austria1CompletedDec 21, 201761
NCT02906917Diabetes Mellitus · United States, Algeria, Czechia and more3CompletedAug 31, 2017532
NCT02844790Healthy · China1CompletedSep 26, 201624
NCT02825251Diabetes Mellitus · United States, Belgium, Canada and more3CompletedJun 20, 2017472
NCT02762578Diabetes Mellitus · China3CompletedMay 19, 2017543
NCT02670915Diabetes Mellitus · United States, Bulgaria, Czechia and more3CompletedFeb 5, 2018834
NCT02648217Diabetes Mellitus · Algeria, India, Lebanon and more3CompletedSep 4, 2016263
NCT02594033Diabetes Mellitus · Germany1CompletedJan 28, 201646
NCT02568280Diabetes Mellitus · Austria1CompletedApr 25, 201642
NCT02500706Diabetes Mellitus · United States, Austria, Bulgaria and more3CompletedJul 17, 20171,108
NCT02131246Diabetes Mellitus · Austria1CompletedJul 201433
NCT02089451Diabetes Mellitus · Germany1CompletedJun 6, 201421
NCT02035371Diabetes Mellitus · Germany1CompletedJul 24, 201441
NCT02033239Diabetes Mellitus · Germany1CompletedJun 201446
NCT02034513Diabetes Mellitus · United States, Poland, Puerto Rico3CompletedJan 11, 2016501
NCT02003677Diabetes Mellitus · Germany1CompletedAug 14, 201467
NCT01999322Diabetes Mellitus · United States, Germany3CompletedMay 14, 201437
NCT01992588Diabetes Mellitus · Germany1CompletedMar 201448
NCT01934712Diabetes Mellitus · Japan1CompletedJan 28, 201450
NCT01924637Diabetes Mellitus · Austria1CompletedNov 201336
NCT01892020Diabetes Mellitus · China4CompletedMay 2014161
NCT01868568Diabetes Mellitus · Germany1CompletedAug 200855
NCT01868555Diabetes Mellitus · Japan1CompletedFeb 200832
NCT01865331Diabetes Mellitus · Germany1CompletedMar 200732
NCT01865305Diabetes Mellitus · Germany1CompletedFeb 200759
NCT01835431Diabetes Mellitus · United States, Belgium, Brazil and more3CompletedNov 7, 2014362
NCT01814137Diabetes Mellitus · United States, Algeria, Germany and more3CompletedMar 201440
NCT01773798Diabetes Mellitus · Austria1CompletedAug 201333
NCT01713530Diabetes Mellitus · United States, Algeria, Austria and more3CompletedJan 9, 2014274
NCT01707134Diabetes Mellitus · Austria, Denmark, Finland and more3CompletedMay 2000753
NCT01704378Diabetes Mellitus · Finland, Norway, Sweden and more4CompletedMar 14, 200389
NCT01698697Diabetes Mellitus · South Africa1CompletedOct 18, 200224
NCT01682902Diabetes Mellitus · United States1CompletedMar 201343
NCT01650129Diabetes Mellitus · Japan3CompletedOct 18, 200183
NCT01620437Diabetes Mellitus · Japan1CompletedDec 30, 200330
NCT01620333Diabetes Mellitus · Japan1CompletedApr 200024
NCT01618188Diabetes Mellitus · Germany1CompletedSep 7, 201252
NCT01538511Diabetes Mellitus · Japan1CompletedMar 13, 200759
NCT01536028Diabetes Mellitus · Germany1CompletedJul 200632
NCT01530048Diabetes Mellitus · Denmark1CompletedMay 200634
NCT01527656Diabetes Mellitus · Germany1CompletedFeb 200440
NCT01527643Diabetes Mellitus · Germany1CompletedDec 17, 200330
NCT01527630Diabetes Mellitus · Japan1CompletedJan 8, 200330
NCT01527565Diabetes Mellitus · South Africa1CompletedFeb 26, 200330
NCT01527552Diabetes Mellitus · South Africa1CompletedDec 18, 200230
NCT01526980Diabetes Mellitus · United Kingdom2CompletedNov 200231
NCT01526941Diabetes Mellitus · Germany1CompletedJul 200127
NCT01524809Diabetes Mellitus · Denmark1CompletedJun 200126
NCT01523041Diabetes Mellitus · United Kingdom1CompletedNov 30, 199924
NCT01520831Diabetes Mellitus · Germany1CompletedMay 200035
NCT01520818Diabetes Mellitus · Belgium, France, Ireland and more3CompletedApr 2001666
NCT01520753Diabetes Mellitus · Denmark3CompletedJun 199916
NCT01486966Diabetes Mellitus · China4TerminatedJun 201258
NCT01486940Diabetes Mellitus · Argentina, Croatia, Czech Republic and more3CompletedOct 2002598
NCT01486914Diabetes Mellitus · United Kingdom1CompletedFeb 24, 200328
NCT01649570Diabetes Mellitus · Japan4CompletedAug 2003123
NCT01469143Diabetes Mellitus · Germany1CompletedJan 201240

How it is read

Names in the registry

  • “insulin aspart”, 60 entries
  • “biphasic insulin aspart”, 27 entries
  • “Faster-acting insulin aspart”, 24 entries
  • “biphasic insulin aspart 50”, 13 entries
  • “biphasic insulin aspart 70”, 12 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.